FDA Shuts The Door On Celgene’s Abraxane Petition
Petition Filed In 2015 Could Have Delayed Competition
ANDA and 505(b)(2) sponsors have been handed a boost after the FDA denied almost entirely a citizen petition filed by Bristol Myers Squibb’s Celgene which called for additional tests for rivals to its Abraxane oncology agent.
